alanine has been researched along with Adult Fanconi Syndrome in 13 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The patient had been treated with lamivudine (LAM) in 2005, LAM+adefovir (ADV) in 2009, and ADV+entecavir in 2015 for chronic hepatitis B (CH-B)." | 3.91 | [Marked improvement in renal tubular markers after switching from adefovir to tenofovir alafenamide in a case of Fanconi syndrome diagnosed through high ALP levels]. ( Hiraoka, A; Izumoto, H; Kitahata, S; Kondoh, K; Michitaka, K; Ninomiya, T; Tsubouchi, E; Ueki, H; Yamago, H, 2019) |
| "No cases of Fanconi syndrome have been reported in clinical trials of TAF." | 1.56 | Renal proximal tubulopathy in an HIV-infected patient treated with tenofovir alafenamide and gentamicin: a case report. ( Bloch, M; Gracey, DM; Heron, JE; Saunders, J; Vanguru, V, 2020) |
| "Acquired Fanconi syndrome has been associated with the long-term ingestion of several nucleoside analogs used to treat chronic hepatitis B virus infection." | 1.51 | A case of entecavir-induced Fanconi syndrome. ( Fujii, T; Kawasoe, K; Nitta, K; Ohta, A, 2019) |
| "Fanconi syndrome is a rare adverse effect of tenofovir disoproxil fumarate (TDF)." | 1.46 | Short Communication: Resolution of Tenofovir Disoproxil Fumarate Induced Fanconi Syndrome with Switch to Tenofovir Alafenamide Fumarate in a HIV-1 and Hepatitis B Coinfected Patient. ( Karris, MY, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Álvarez, H | 1 |
| Llibre, JM | 1 |
| Bahr, NC | 2 |
| Yarlagadda, SG | 2 |
| Leungsuwan, S | 1 |
| Hooi, B | 1 |
| Myint, KS | 1 |
| Heron, JE | 1 |
| Bloch, M | 1 |
| Vanguru, V | 1 |
| Saunders, J | 1 |
| Gracey, DM | 1 |
| Karris, MY | 1 |
| Kondoh, K | 1 |
| Michitaka, K | 1 |
| Hiraoka, A | 1 |
| Izumoto, H | 1 |
| Ueki, H | 1 |
| Kitahata, S | 1 |
| Yamago, H | 1 |
| Tsubouchi, E | 1 |
| Ninomiya, T | 1 |
| Fujii, T | 1 |
| Kawasoe, K | 1 |
| Ohta, A | 1 |
| Nitta, K | 1 |
| Ray, AS | 1 |
| Fordyce, MW | 1 |
| Hitchcock, MJ | 1 |
| Garcia, M | 1 |
| Le Moal, G | 1 |
| Godet, C | 1 |
| Beraud, G | 1 |
| Chagneau-Derrode, C | 1 |
| Roblot, F | 1 |
| Cetinkaya, I | 1 |
| Schlatter, E | 1 |
| Hirsch, JR | 1 |
| Herter, P | 1 |
| Harms, E | 1 |
| Kleta, R | 1 |
| Castaño, E | 1 |
| Marzabal, P | 1 |
| Casado, FJ | 1 |
| Felipe, A | 1 |
| Pastor-Anglada, M | 1 |
| Reynolds, R | 1 |
| McNamara, PD | 1 |
| Segal, S | 1 |
1 review available for alanine and Adult Fanconi Syndrome
| Article | Year |
|---|---|
Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus.
Topics: Adenine; Alanine; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bone Density; Dru | 2016 |
12 other studies available for alanine and Adult Fanconi Syndrome
| Article | Year |
|---|---|
Fanconi Syndrome and Tenofovir Alafenamide.
Topics: Adenine; Alanine; Anti-HIV Agents; Fanconi Syndrome; Humans; Tenofovir | 2019 |
Fanconi Syndrome and Tenofovir Alafenamide.
Topics: Adenine; Alanine; Anti-HIV Agents; Fanconi Syndrome; Humans; Tenofovir | 2019 |
Hypophosphatemic Osteomalacia Due to Adefovir-Induced Fanconi Syndrome.
Topics: Adenine; Aged; Alanine; Antiviral Agents; Fanconi Syndrome; Female; Hepatitis C, Chronic; Humans; Hy | 2020 |
Renal proximal tubulopathy in an HIV-infected patient treated with tenofovir alafenamide and gentamicin: a case report.
Topics: Acute Disease; Alanine; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Antiv | 2020 |
Short Communication: Resolution of Tenofovir Disoproxil Fumarate Induced Fanconi Syndrome with Switch to Tenofovir Alafenamide Fumarate in a HIV-1 and Hepatitis B Coinfected Patient.
Topics: Adenine; Alanine; Anti-HIV Agents; Coinfection; Fanconi Syndrome; Hepatitis B, Chronic; HIV Infectio | 2017 |
Fanconi Syndrome and Tenofovir Alafenamide: A Case Report.
Topics: Adenine; Alanine; Antiviral Agents; Fanconi Syndrome; HIV Infections; Humans; Male; Middle Aged; Ten | 2019 |
[Marked improvement in renal tubular markers after switching from adefovir to tenofovir alafenamide in a case of Fanconi syndrome diagnosed through high ALP levels].
Topics: Adenine; Alanine; Alkaline Phosphatase; Antiviral Agents; Biomarkers; DNA, Viral; Drug Resistance, V | 2019 |
A case of entecavir-induced Fanconi syndrome.
Topics: Acidosis; Acute Kidney Injury; Adenine; Aged; Alanine; Antiviral Agents; Fanconi Syndrome; Guanine; | 2019 |
First case report of renal improvement on tenofovir alafenamide in an HIV/hepatitis B virus-coinfected patient with adefovir-induced Fanconi's syndrome.
Topics: Absorptiometry, Photon; Adenine; Alanine; Coinfection; Dose-Response Relationship, Drug; Fanconi Syn | 2016 |
Inhibition of Na(+)-dependent transporters in cystine-loaded human renal cells: electrophysiological studies on the Fanconi syndrome of cystinosis.
Topics: Alanine; Amino Acid Transport Systems, Neutral; Cell Line; Cystine; Electrophysiology; Fanconi Syndr | 2002 |
Na+,K(+)-ATPase expression in maleic-acid-induced Fanconi syndrome in rats.
Topics: Alanine; Animals; Biological Transport; Fanconi Syndrome; Glucose; Kidney Cortex; Male; Maleates; Mi | 1997 |
On the maleic acid induced Fanconi syndrome: effects on transport by isolated rat kidney brushborder membrane vesicles.
Topics: Alanine; Animals; Cell Membrane; Fanconi Syndrome; Fumarates; Kidney; Lysine; Male; Maleates; Methyl | 1978 |